Data Collection Analysis Business Management
9
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
Role: lead
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Role: lead
Healthcare Decisions on Dietary and Environmental Allergen Exposure
Role: lead
Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies
Role: lead
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
Role: lead
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Role: lead
Usage and Plan of Care Changes Due to Drug Screenings
Role: lead
A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
Role: lead
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
Role: lead
All 9 trials loaded